Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Lung Cancer Minimal Residual Disease Detection Using an Integrated cfDNA and cfRNA Approach

Reference number
Coordinator Oncodia AB
Funding from Vinnova SEK 4 992 000
Project duration June 2025 - June 2028
Status Ongoing
Venture Eurostars

Last updated 25 March 2025

Reference number 2025-00040